PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:39 - 48
Updated:12/1/2018
Start Date:September 2013
End Date:November 2017

Use our guide to learn which trials are right for you!

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool

In order to better communicate personal risk of breast cancer to women who have not yet
initiated breast cancer screening (mammography), The Annenberg School of Communication at the
University of Pennsylvania has created a personal breast cancer screening decision aid tool.
This tool will be pilot tested, and then implemented and tested in nine primary care and
OB/GYN practices within the University of Pennsylvania Health System.

In order to better communicate personal risk of breast cancer to women who have not yet
initiated breast cancer screening (mammography), The Annenberg School of Communication at the
University of Pennsylvania has created a personal breast cancer screening decision aid tool.
This tool incorporates questions about a women's personal history of breast cancer and
compares her to the average women her age in terms of breast cancer risk. The tool helps the
women to understand the benefits and risks of breast cancer screening. This tool will be
pilot tested using SSI to help develop the final version of the decision aid tool. The
decision aid tool will then be implemented and tested in nine general internal medicine,
family medicine, and OB/GYN practices within the University of Pennsylvania Health System.

Inclusion Criteria:

- Women ages 39-48

- Patient of one of the nine primary care or OB/GYN practices that are participating in
the study

- Must have had an appointment at one of these locations in the past 24 months

- Must have an appointment during the study period

- Woman has not yet initiated breast cancer screening (no prior mammogram)

- No history of breast cancer

Exclusion Criteria:

- Prior diagnosis of breast cancer

- Major comorbidity that substantially affects their 10 year mortality

- Non-English speaker
We found this trial at
9
sites
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radnor, Pennsylvania 19087
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Radnor, PA
Click here to add this to my saved trials
Radnor, Pennsylvania 19087
Principal Investigator: Marilyn Schapira, MD, MPH
Phone: 215-898-2022
?
mi
from
Radnor, PA
Click here to add this to my saved trials